Alli and Insulin NPH and Insulin Regular
Determining the interaction of Alli and Insulin NPH and Insulin Regular and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:As you lose weight during treatment with orlistat, your dosage requirement of insulin regular or any other diabetic medications you are receiving may change. You may need more frequent monitoring of your blood sugar and adjustment of your diabetic regimen both during and after treatment with orlistat. Let your doctor know if you experience hypoglycemia, or low blood sugar. Symptoms of hypoglycemia include headache, dizziness, drowsiness, nervousness, confusion, tremor, nausea, hunger, weakness, perspiration, palpitation, and rapid heartbeat. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Professional:MONITOR: Since weight loss may affect glycemic control and increase the risk of hypoglycemia in type 2 diabetes mellitus, patients receiving anorectic drugs may require periodic adjustments of their antidiabetic medications.
MANAGEMENT: Blood glucose should be closely monitored during weight loss treatment, and appropriate changes made to the antidiabetic drug regimen as needed. Patients should be apprised of the risk of hypoglycemia and be alert to potential signs and symptoms such as headache, dizziness, drowsiness, nervousness, confusion, tremor, hunger, weakness, perspiration, palpitation, and tachycardia. For antidiabetic medications that are not glucose-dependent, reduction in the dosage should be considered to mitigate the risk of hypoglycemia.
- "Product Information. Xenical (orlistat)." Roche Laboratories, Nutley, NJ.
- "Product Information. Didrex (benzphetamine)" Pharmacia and Upjohn, Kalamazoo, MI.
- "Product Information. Suprenza (phentermine)." Akrimax Pharmaceuticals, Cranford, NJ.
- "Product Information. Belviq (lorcaserin)." Eisai Inc, Teaneck, NJ.
Generic Name: insulin isophane / insulin regular
Brand name: Humulin 70/30, HumuLIN 70/30 KwikPen, Novolin 70/30, ReliOn/Novolin 70/30, Humulin 50/50, Insulin Pork Mix, HumuLIN 70/30 Pen, NovoLIN 70/30 Innolet, NovoLIN 70/30 PenFill, Relion NovoLIN 70/30 Innolet, NovoLIN 70/30 FlexPen, ReliOn/NovLIN 70/30 FlexPen, Humulin 50/50, Novolin 70/30
Synonyms: Insulin isophane and insulin regular
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Alli-Insulin NPH and Insulin Regular (InnoLets, Pens, and PenFills)
- Alli-Insulin NPH and Insulin Regular (Vials)
- Alli-Insulin Parenteral
- Alli-Insulin regular
- Alli-Insulin Regular (U-100) Cartridges & Prefilled Syringes
- Alli-Insulin Regular (U-100) Vials
- Insulin NPH and Insulin Regular-Allopurinol
- Insulin NPH and Insulin Regular-Allopurinol and lesinurad
- Insulin NPH and Insulin Regular-Allopurinol Injection
- Insulin NPH and Insulin Regular-Allopurinol Intravenous
- Insulin NPH and Insulin Regular-Allopurinol Tablets
- Insulin NPH and Insulin Regular-Allzital